These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28003126)

  • 21. Hippo-yap signaling in ocular development and disease.
    Lee M; Goraya N; Kim S; Cho SH
    Dev Dyn; 2018 Jun; 247(6):794-806. PubMed ID: 29532607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulation of Yorkie, YAP and TAZ: new insights into the Hippo pathway.
    Manning SA; Kroeger B; Harvey KF
    Development; 2020 Apr; 147(8):. PubMed ID: 32341025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
    Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
    Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation.
    Lin Z; Pu WT
    Stem Cell Res; 2014 Nov; 13(3 Pt B):571-81. PubMed ID: 24881775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Hippo pathway in normal development and cancer.
    Maugeri-Saccà M; De Maria R
    Pharmacol Ther; 2018 Jun; 186():60-72. PubMed ID: 29305295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors.
    Cebola I; Rodríguez-Seguí SA; Cho CH; Bessa J; Rovira M; Luengo M; Chhatriwala M; Berry A; Ponsa-Cobas J; Maestro MA; Jennings RE; Pasquali L; Morán I; Castro N; Hanley NA; Gomez-Skarmeta JL; Vallier L; Ferrer J
    Nat Cell Biol; 2015 May; 17(5):615-626. PubMed ID: 25915126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
    Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IQGAP1 Binds to Yes-associated Protein (YAP) and Modulates Its Transcriptional Activity.
    Sayedyahossein S; Li Z; Hedman AC; Morgan CJ; Sacks DB
    J Biol Chem; 2016 Sep; 291(37):19261-73. PubMed ID: 27440047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration.
    Wang J; Liu S; Heallen T; Martin JF
    Nat Rev Cardiol; 2018 Nov; 15(11):672-684. PubMed ID: 30111784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development.
    Rozengurt E; Eibl G
    World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
    Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
    PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Myocardial Cell Growth and Death by the Hippo Pathway.
    Ikeda S; Sadoshima J
    Circ J; 2016 Jun; 80(7):1511-9. PubMed ID: 27302848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
    Crawford JJ; Bronner SM; Zbieg JR
    Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
    [No Abstract]   [Full Text] [Related]  

  • 34. Hippo pathway effector Yap promotes cardiac regeneration.
    Xin M; Kim Y; Sutherland LB; Murakami M; Qi X; McAnally J; Porrello ER; Mahmoud AI; Tan W; Shelton JM; Richardson JA; Sadek HA; Bassel-Duby R; Olson EN
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13839-44. PubMed ID: 23918388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
    Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
    EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteine residues are essential for dimerization of Hippo pathway components YAP2L and TAZ.
    Khanal P; Jia Z; Yang X
    Sci Rep; 2018 Feb; 8(1):3485. PubMed ID: 29472569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
    Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
    FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual role of YAP and TAZ in renewal of the intestinal epithelium.
    Imajo M; Ebisuya M; Nishida E
    Nat Cell Biol; 2015 Jan; 17(1):7-19. PubMed ID: 25531778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas.
    Gao T; Zhou D; Yang C; Singh T; Penzo-Méndez A; Maddipati R; Tzatsos A; Bardeesy N; Avruch J; Stanger BZ
    Gastroenterology; 2013 Jun; 144(7):1543-53, 1553.e1. PubMed ID: 23454691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.